Dec. 9: FDA approval decision for Human Genome Sciences' ( HGSI) lupus drug Benlysta. Dec. 14: Onyx Pharmaceuticals investor/analyst meeting. Dec. 16: FDA approval decision for AstraZeneca's ( AZN) blood thinner Brilinta. Dec. 29: FDA approval decision for Alimera Sciences' ( ALIM) Iluvien for treatment of diabetic macular edema. FDA approval decision for MannKind's ( MNKD) inhaled insuline device Afrezza --Written by Adam Feuerstein in Boston. >To contact the writer of this article, click here: Adam Feuerstein. >To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein. >To submit a news tip, send an email to: firstname.lastname@example.org.